Email not displaying properly? View email in your browser
Vertical-Talk Pharma    Magnetic Nanoparticles
 3D imaging Capability
 Crizanlizumab Treatment
Mar 2019   e-Newsletter Media Pack    |    Advertise
Follow Us Facebook Twitter Google Plus Linkedin
Zebra Healthcare
News
NapaJen Pharma and Astellas Pharma Establish...
Merck collaborates with GenScript to accelerate...
Pfizer Secures Exclusive Option to Acquire Gene...
 
Press Releases
Highlighting Advantages of the Whole-industry...
Turkish Cargo sponsored the carriage of historical...
Primex Pharmaceuticals and Nordic Group Sign...
 
Events
02 -05 Apr 2019
BioProcess International Europe
11 -14 Apr 2019
IDEX Istanbul
15 -16 Apr 2019
12th European Biosimilars Congress
Articles
  Nanomedicines management for advance therapy of NeuroAIDS...
Md. Habban Akhter, Faculty of Pharmacy; DIT University Dehradun, India
The AIDS/acquired Immune deficiency syndrome associated with their significance role in the development of HIV infection that later stage lead to broad range of complicated neurological disorder including neuroAIDS. The complication of neuroAIDS involves cognitive impairment, dementia, loss of sensation prominently in legs and arms and behavioral...
ACG Engineering
Techno Trends
  Nottingham University Launches First-of-its-kind Equipment for...
  Novartis Announces Crizanlizumab (SEG101) for Prevention...
Vetter pharma
Projects
  Nanoform Announces Construction of GMP Manufacturing Plant...
  Orchard Therapeutics Announces Plans to Build Gene Therapy...
CPhI & P-MEC China 2019
Turkish Cargo
e-Magazine  |  Subscribe  |  Unsubscribe  |  Previous Issues  |  Advisory Board  |  Editorial Calendar  |  Archives
www.pharmafocusasia.com - Owned by Ochre Media Pvt. Ltd.
Tel: +91 40 4961 4567 | Fax: +91 40 4961 4555